Alumis (ALMS) announced that its stockholders voted to approve all proposals required to be approved in connection with the pending merger with ACELYRIN (SLRN) at its Special Meeting of Stockholders. The final voting results of the Alumis Special Meeting will be reported in a Form 8-K filed by Alumis with the U.S. Securities and Exchange Commission. The merger is expected to close in the second quarter of 2025, subject to satisfaction of certain customary closing conditions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALMS:
- Largest borrow rate increases among liquid names
- Acelyrin urges stockholders to vote for proposed merger with Alumis
- Confident Outlook on Acelyrin-Alumis Merger Amid Shareholder Opposition
- Alumis price target lowered to $14 from $15 at H.C. Wainwright
- Alumis and Acelyrin sign ammended merger agreement